Current Research Projects - Blog Style

Agency: NIH/NIMH
Agency Award Number: 1R01MH08754-01A1

To study the implementation of an efficacious intervention to reduce STIs among female sex workers.

Agency: Merck Pharm
Agency Award Number: 33132

This project will estimate the penetration of Raltegravir into the brain by
measuring its concentrations in CSF and estimate the antiviral effectiveness
in the brain of Raltegravir by measuring HIV RNA levels in CSF.

Agency: NIH/NIMH

Agency Award Number: 5R01NS051132-05

Agency: NIH/NIAID

Agency Award Number: 5R01AI047033-06

To determine the prevalence of transmitted drug resistant variants including those that may be resistant to new antiretroviral targets such as inhibitors of viral fusion (enfuvirtide) and integration.

Agency: NIH/NIMH

Agency Award Number: 5R01MH083552-02

To characterize and compare the burden of HIV associated neurocognitive disorders (HAND) occurring among individuals living in Brazil, China, India, Romania and the United States, and to evaluate the neurovirulent and neurotropic genotypic determinants between subtypes.

Agency: NIH/NIMH

Agency Award Number: 5R01MH085608-02

To determine the novel role of mannose binding lectin in susceptibility of HIV-1 infection in brain and related neuroinflammation, viral protein accumulation and neurocognitive impairment.